申请人:LILLY INDUSTRIES LIMITED
公开号:EP0805147A1
公开(公告)日:1997-11-05
The compounds of formula I and derivatives thereof have been found to be active in tests that show modulation of voltage-dependent calcium channels, and are thus indicated for use in the treatment of diseases in which such modulation is beneficial, in particular diseases of the central nervous system.
公式I及其衍生物的化合物已被发现在显示调节电压依赖性钙通道的测试中具有活性,因此适用于治疗对此类调节有益的疾病,特别是中枢神经系统疾病。